Translator Disclaimer
Presentation
6 March 2020 In vivo diagnosis of idiopathic pulmonary fibrosis (IPF) using endobronchial OCT (Conference Presentation)
Author Affiliations +
Proceedings Volume 11214, Endoscopic Microscopy XV; 112140B (2020) https://doi.org/10.1117/12.2541981
Event: SPIE BiOS, 2020, San Francisco, California, United States
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD). High-resolution CT (HRCT) is currently used to identify macroscopic IPF features. However, for 50% of patients, ultimate diagnosis relies on microscopic features from invasive, high-risk surgical biopsies (SLBX). We conducted a pilot study to assess endobronchial OCT (EB-OCT) for in vivo diagnosis of IPF, enrolling ILD patients with nondiagnostic HRCT undergoing SLBX. EB-OCT visualized salient IPF features, including microscopic features not visible on HRCT, and accurately diagnosed IPF and non-IPF ILD as compared with SLBX. EB-OCT has the potential for in vivo microscopic diagnosis of IPF.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Sreyankar Nandy, Benjamin W. Roop, David C. Adams, Ashok Muniappan, Colleen M. Keyes, John C. Wain, Christopher R. Morse, Michael Lanuti, Thomas V. Colby, Angela Shih, Mari Mino-Kenudson, Eugene J. Mark, Richard L. Kradin, Amita Sharma, Lloyd Liang, Diane L. Davies, Margit V. Szabari, Andrew M. Tager, Melissa J. Suter, and Lida P. Hariri "In vivo diagnosis of idiopathic pulmonary fibrosis (IPF) using endobronchial OCT (Conference Presentation)", Proc. SPIE 11214, Endoscopic Microscopy XV, 112140B (6 March 2020); https://doi.org/10.1117/12.2541981
PROCEEDINGS
PRESENTATION


SHARE
Advertisement
Advertisement
Back to Top